Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Methylation
48%
Tumor Suppressor Gene
40%
Epidermal Growth Factor Receptor
40%
Loss of Heterozygosity
30%
P53
26%
Promoter Region
26%
Oncogene
25%
Gene Mutation
25%
Genetics
22%
Carcinogenesis
21%
Allele
21%
Gene Expression
20%
KRAS
16%
Tumor Suppressor Protein
15%
DNA Methylation
14%
Messenger RNA
13%
Epigenetics
12%
Tumor Progression
12%
Smoking
11%
Mouse
11%
Cell Growth
10%
Exon
10%
Wild Type
10%
Mesenchymal-Epithelial Transition
9%
Mouse Model
9%
Protein P53
9%
RNA
9%
Signal Transduction
9%
Gene Expression Profiling
9%
Kinase
8%
Phosphotransferase
8%
Transcription Factors
8%
Single-Nucleotide Polymorphism
8%
Microsatellite DNA
8%
Codon
7%
Cell Proliferation
7%
Chromosome 3
7%
Receptor Gene
7%
Chromosome 3p
7%
MicroRNA
6%
Morphology
6%
Precursor
6%
Human Chromosome
6%
Transcription
6%
Drug Resistance
5%
Candidate Gene
5%
Cell Culture
5%
Protein Expression
5%
FHIT
5%
Myc
5%
Telomerase
5%
Epigenomics
5%
Amino Acids
5%
Microarrays
5%
Downregulation
5%
Point Mutation
5%
Polymerase Chain Reaction
5%
Microsatellite Marker
5%
Isoform
5%
Colon
5%
Medicine and Dentistry
Lung Cancer
97%
Neoplasm
65%
Small Cell Lung Cancer
60%
Non Small Cell Lung Cancer
53%
Malignant Neoplasm
33%
Cell Line
33%
Lung Cancer Cell Line
30%
Methylation
21%
Epidermal Growth Factor Receptor
20%
Cancer Cell
18%
Disease
16%
Adenocarcinoma
16%
Lung Adenocarcinoma
14%
Tumor Suppressor Gene
14%
Small-Cell Carcinoma
14%
Gene Expression
13%
In Vitro
12%
Gene Mutation
12%
Metastatic Carcinoma
12%
Protein P53
11%
Breast Cancer
11%
Squamous Cell Carcinoma
10%
Promoter Region
10%
Epithelial Cell
10%
Non-Small Cell Lung Cancer
9%
Lung Carcinoma
9%
Tumor Cell
9%
Lung Tumor
8%
Heterozygosity
8%
Telomerase
8%
Tumor Cell Line
8%
Biological Marker
7%
Smoking
7%
Targeted Therapy
6%
Radiation Therapy
6%
Biopsy
6%
Carcinoma
6%
Oncogene
6%
Combination Chemotherapy
6%
Tumor Progression
6%
Drug Resistance
6%
Etoposide
5%
Cancer
5%
Carcinogenesis
5%
Cutaneous T Cell Lymphoma
5%
Morphology
5%
Molecular Pathology
5%
Ras Signaling
5%
Lymphocyte
5%
Diagnosis
5%
Keyphrases
Lung Cancer
46%
Non-small Cell Lung Cancer (NSCLC)
30%
Small Cell Lung Cancer
27%
Tumor
21%
Lung Cancer Cell Lines
15%
Tumor Suppressor Gene
12%
Non-small Cell Lung Cancer Cells
10%
Lung Carcinoma
10%
Methylation
10%
Small Cell Carcinoma
9%
Oncogene
9%
Human Lung Cancer Cell Line
9%
Loss of Heterozygosity
9%
Promoter Methylation
8%
Aberrant Methylation
8%
Tumor Cell Lines
7%
Gene Expression
6%
Small Cell Lung Carcinoma
6%
Small Cell
6%
Breast Cancer
6%
RASSF1A
6%
3p21.3
6%
Tumor Cells
5%
Human Cancer
5%
Adenocarcinoma
5%
Homozygous Deletion
5%
Cancer Tumor
5%
Lung Cancer Cells
5%
Lung Adenocarcinoma
5%
KRAS mutation
5%
Monoclonal Antibody
5%
Human Lung Cancer
5%